| |
| |
|
| Insider
Information: |
Tombesi Paolo |
| Relationship: |
EVP & Chief Financial ... |
| City: |
Bridgewater |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
64,134 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$351,613 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
64,134 |
|
|
| Total
Value |
$351,613 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -100.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Insmed Inc |
INSM |
Chief Financial Officer |
2018-01-04 |
10,669 |
2018-01-04 |
0 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
Chief Financial Officer |
2021-02-04 |
53,465 |
2020-01-23 |
0 |
Premium* |
|
|
Turning Point Therapeutics, Inc. |
TPTX |
EVP & Chief Financial ... |
2022-08-17 |
0 |
2021-07-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Financial Officer |
• – – |
2022-08-17 |
4 |
D |
$76.00 |
$2,263,128 |
D/D |
(29,778) |
0 |
0 |
- |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Financial Officer |
• – – |
2022-07-27 |
4 |
S |
$74.94 |
$88,654 |
D/D |
(1,183) |
28,700 |
0 |
% |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Financial Officer |
• – – |
2022-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
16,283 |
29,883 |
0 |
- |
|
| TPTX |
Turning Point Therapeutic... |
EVP & Chief Financial Officer |
• – – |
2021-07-26 |
4 |
A |
$0.00 |
$0 |
D/D |
13,600 |
13,600 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$11,445 |
D/D |
(1,021) |
53,465 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,041 |
54,486 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-08-20 |
4 |
D |
$12.55 |
$26,242 |
D/D |
(2,091) |
26,906 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,055 |
28,997 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-06-26 |
4 |
AS |
$16.15 |
$29,151 |
D/D |
(1,805) |
21,942 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
23,747 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-03-25 |
4 |
AS |
$15.28 |
$18,993 |
D/D |
(1,243) |
15,437 |
0 |
% |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,690 |
16,680 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
11,688 |
14,990 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-01-23 |
4 |
D |
$26.72 |
$45,371 |
D/D |
(1,698) |
3,302 |
0 |
- |
|
| EPZM |
Epizyme, Inc. |
Chief Financial Officer |
• – – |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| INSM |
Insmed Inc |
Chief Financial Officer |
• – – |
2018-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,669 |
10,669 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
